drugset / Trial / NCT06351917

Effect of Topical PlexoZome® Levagen® Spray on Relief of Post Exercise Knee Joint Pain

NCT06351917 ↗

Phase 4 Completed 80 enrolled RDC Clinical Pty Ltd
RandomizedParallel-groupDouble-blindTreatment

Summary

This is a randomised, double-blind, placebo controlled, 2 arm parallel clinical trial to evaluate the effect of topical PlexoZome® Levagen® spray on relief of post exercise knee joint pain in healthy adults compared to placebo over 4 weeks duration.

Timeline

Start
2024-04-24
Primary completion
2024-06-18
Completion
2024-06-18

Drugs

EvaluationDrugModalityDoseRoute
Subject PlexoZome® Levagen® Unknown 5.6 mg Topical

Indications